Literature DB >> 8910964

A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.

D Faraggi1, R Simon.   

Abstract

Continuous measurements are often dichotomized for classification of subjects. This paper evaluates two procedures for determining a best cutpoint for a continuous prognostic factor with right censored outcome data. One procedure selects the cutpoint that minimizes the significance level of a logrank test with comparison of the two groups defined by the cutpoint. This procedure adjusts the significance level for maximal selection. The other procedure uses a cross-validation approach. The latter easily extends to accommodate multiple other prognostic factors. We compare the methods in terms of statistical power and bias in estimation of the true relative risk associated with the prognostic factor. Both procedures produce approximately the correct type I error rate. Use of a maximally selected cutpoint without adjustment of the significance level, however, results in a substantially elevated type I error rate. The cross-validation procedure unbiasedly estimated the relative risk under the null hypothesis while the procedure based on the maximally selected test resulted in an upward bias. When the relative risk for the two groups defined by the covariate and true changepoint was small, the cross-validation procedure provided greater power than the maximally selected test. The cross-validation based estimate of relative risk was unbiased while the procedure based on the maximally selected test produced a biased estimate. As the true relative risk increased, the power of the maximally selected test was about 10 per cent greater than the power obtained using cross-validation. The maximally selected test overestimated the relative risk by about 10 per cent. The cross-validation procedure produced at most 5 per cent underestimation of the true relative risk. Finally, we report the effect of dichotomizing a continuous non-linear relationship between covariate and risk. We compare using a linear proportional hazard model to using models based on optimally selected cutpoints. Our simulation study indicates that we can have a substantial loss of statistical power when we use cutpoint models in cases where there is a continuous relationship between covariate and risk.

Mesh:

Year:  1996        PMID: 8910964     DOI: 10.1002/(SICI)1097-0258(19961030)15:20<2203::AID-SIM357>3.0.CO;2-G

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  46 in total

1.  Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.

Authors:  Lucie M Turcotte; Qing Cao; Sarah A Cooley; Julie Curtsinger; Shernan G Holtan; Xianghua Luo; Ashely Yingst; Daniel J Weisdorf; Bruce R Blazar; Jeffrey S Miller; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2019-01-06       Impact factor: 5.742

2.  Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.

Authors:  Benjamin Houdu; Charline Lasnon; Idlir Licaj; Guy Thomas; Pascal Do; Anne-Valerie Guizard; Cédric Desmonts; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-14       Impact factor: 9.236

3.  Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Weihua Guan; Jing Cao; Brian T Steffen; Wendy S Post; James H Stein; Mathew C Tattersall; Joel D Kaufman; Joseph P McConnell; Daniel M Hoefner; Russell Warnick; Michael Y Tsai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-19       Impact factor: 8.311

4.  Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Authors:  Maja Guberina; Wilfried Eberhardt; Martin Stuschke; Thomas Gauler; Clemens Aigner; Martin Schuler; Georgios Stamatis; Dirk Theegarten; Walter Jentzen; Ken Herrmann; Christoph Pöttgen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-01       Impact factor: 9.236

5.  Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study.

Authors:  Moonseong Heo; Geoffrey C Kabat; Howard D Strickler; Juan Lin; Lifang Hou; Marcia L Stefanick; Garnet L Anderson; Thomas E Rohan
Journal:  J Womens Health (Larchmt)       Date:  2015-01-14       Impact factor: 2.681

6.  Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.

Authors:  Jae Seok Bae; Dong Ho Lee; Jeongin Yoo; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Haeryoung Kim; Kyung Bun Lee
Journal:  Eur Radiol       Date:  2020-10-07       Impact factor: 5.315

7.  Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.

Authors:  Vít Procházka; Rakhee S Gawande; Zuzan Cayci; Jerry W Froelich; Qing Cao; Chris Wilke; Kathryn Dusenbery; Daniel J Weisdorf; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

8.  Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Authors:  Kala Visvanathan; MaryJo S Fackler; Zhe Zhang; Zoila A Lopez-Bujanda; Stacie C Jeter; Lori J Sokoll; Elizabeth Garrett-Mayer; Leslie M Cope; Christopher B Umbricht; David M Euhus; Andres Forero; Anna M Storniolo; Rita Nanda; Nancy U Lin; Lisa A Carey; James N Ingle; Saraswati Sukumar; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

9.  Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction.

Authors:  Bernhard Mlecnik; Fatima Sanchez-Cabo; Pornpimol Charoentong; Gabriela Bindea; Franck Pagès; Anne Berger; Jerome Galon; Zlatko Trajanoski
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

10.  Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.

Authors:  Dong Ho Lee; Jeong Min Lee; Nam-Joon Yi; Kwang-Woong Lee; Kyung-Suk Suh; Jeong-Hoon Lee; Kyung Bun Lee; Joon Koo Han
Journal:  Eur Radiol       Date:  2016-07-25       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.